APA (7th ed.) Citation

Lee, K., Bang, K., Yoo, C., Hwang, I., Jeong, J. H., Chang, H., . . . Ryoo, B. (2020). Clinical Outcomes of Second-Line Chemotherapy after Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma. Cancer research and treatment, 52(1), 254-262. https://doi.org/10.4143/crt.2019.190

Chicago Style (17th ed.) Citation

Lee, Kyoungmin, et al. "Clinical Outcomes of Second-Line Chemotherapy After Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma." Cancer Research and Treatment 52, no. 1 (2020): 254-262. https://doi.org/10.4143/crt.2019.190.

MLA (9th ed.) Citation

Lee, Kyoungmin, et al. "Clinical Outcomes of Second-Line Chemotherapy After Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma." Cancer Research and Treatment, vol. 52, no. 1, 2020, pp. 254-262, https://doi.org/10.4143/crt.2019.190.